Items where authors include "King, A."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 23.

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Keaveney, S. orcid.org/0000-0001-7715-0750, Dragan, A., Rata, M. et al. (25 more authors) (2023) Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study. Insights into Imaging, 14 (1). 170.

Gooday, G. orcid.org/0000-0002-4300-471X, King, A. and Spurna, N. (2023) 1876 and All That: the ‘Special Loan Collection of Scientific Apparatus’ as a case study in crowd-sourced international public science. Science Museum Group Journal. ISSN 2054-5770

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine. ISSN 1078-8956

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29 (7). pp. 1760-1774. ISSN 1078-8956

Hood, R., Goldacre, A., Jones, E. et al. (3 more authors) (2023) Categorising demand for child welfare services using latent class analysis: a study of the national data-sets on children in need in England. The British Journal of Social Work. ISSN 0045-3102

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Lakha, F., King, A., Swinkels, K. et al. (1 more author) (2022) Are schools drivers of COVID-19 infections — an analysis of outbreaks in Colorado, USA in 2020. Journal of Public Health, 44 (1). e26-e35. ISSN 1741-3842

Gkazi, S.A., Troakes, C., Topp, S. et al. (10 more authors) (2019) Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia. Neurobiology of Aging, 73. 229.e5-229.e9. ISSN 0197-4580

Bird, E.V., Iannitti, T., Christmas, C. et al. (4 more authors) (2018) A novel role for lymphotactin (XCL1) signaling in the nervous system: XCL1 acts via its receptor XCR1 to increase trigeminal neuronal excitability. Neuroscience, 379. pp. 334-349. ISSN 0306-4522

Kovacs, G.G., Xie, S.X., Lee, E.B. et al. (59 more authors) (2017) Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG). Journal of Neuropathology and Experimental Neurology, 76 (7). pp. 605-619. ISSN 0022-3069

Smith, B.N., Topp, S.D., Fallini, C. et al. (53 more authors) (2017) Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Science Translational Medicine, 9 (388). eaad9157. ISSN 1946-6234

Kenna, K.P., van Doormaal, P.T.C., Dekker, A.M. et al. (92 more authors) (2016) NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nature Genetics, 48 (9). pp. 1037-1042. ISSN 1061-4036

Redman, M., King, A., Watson, C. et al. (1 more author) (2016) What is CRISPR/Cas9? Archives of Disease in Childhood, 101. pp. 213-215. ISSN 0003-9888

Speakman, J.R., Blount, J.D., Bronikowski, A.M. et al. (25 more authors) (2015) Oxidative stress and life histories: unresolved issues and current needs. ECOLOGY AND EVOLUTION, 5 (24). S745-S757. ISSN 2045-7758

Jones, A.R., Troakes, C., King, A. et al. (13 more authors) (2015) Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes. Neurobiology of Aging, 36 (5). 2006.e1-2006.e9. ISSN 0197-4580

Smith, B.N., Ticozzi, N., Fallini, C. et al. (63 more authors) (2014) Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS. Neuron, 84 (2). pp. 324-331. ISSN 0896-6273

Alafuzoff, I., Arzberger, T., Al-Sarraj, S. et al. (27 more authors) (2008) Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe consortium. Brain Pathology, 18 (4). pp. 484-496. ISSN 1015-6305

Zhu, N., Lalla, R., Eves, P. et al. (5 more authors) (2004) Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone. British Journal of Cancer, 90 (7). 1457 - 1463. ISSN 0007-0920

Smaus, J.-G., Hill, P.M. and King, A. (2001) Verifying termination and error-freedom of logic programs with block declarations. Theory and Practice of Logic Programming, 1 (4). pp. 447-486. ISSN 1471-0684

Bridgeland, T., King, A. and Reid, M. (2001) The McKay correspondence as an equivalence of derived categories. Journal of the American Mathematical Society, 14 (3). pp. 535-554. ISSN 0894-0347

This list was generated on Sun Apr 14 00:45:05 2024 BST.